Article Type
Changed
Fri, 01/04/2019 - 11:05
Display Headline
Community Oncology Podcast - Targeted therapies in multiple myeloma

Join community Oncology's Editor-in-Chief Dr. David Henry for an audio tour of the March issue, featuring Dr. Kenneth C. Anderson's review of targeted therapies in multiple myeloma, Dr. Stuart M. Lichtman's commentary on treating cancer in elderly patients, and Dr. Jame Abraham's Community Translation article on vemurafenib for melanoma with the BRAF V600E mutation.

Author and Disclosure Information

Audio / Podcast
Publications
Topics
Legacy Keywords
Dr. David Henry, Dr. Kenneth C. Anderson, multiple myeloma, Dr. Stuart M. Lichtman, Dr. Jame Abraham, vemurafenib for melanoma, BRAF V600E mutation.
Audio / Podcast
Audio / Podcast
Author and Disclosure Information

Author and Disclosure Information

Join community Oncology's Editor-in-Chief Dr. David Henry for an audio tour of the March issue, featuring Dr. Kenneth C. Anderson's review of targeted therapies in multiple myeloma, Dr. Stuart M. Lichtman's commentary on treating cancer in elderly patients, and Dr. Jame Abraham's Community Translation article on vemurafenib for melanoma with the BRAF V600E mutation.

Join community Oncology's Editor-in-Chief Dr. David Henry for an audio tour of the March issue, featuring Dr. Kenneth C. Anderson's review of targeted therapies in multiple myeloma, Dr. Stuart M. Lichtman's commentary on treating cancer in elderly patients, and Dr. Jame Abraham's Community Translation article on vemurafenib for melanoma with the BRAF V600E mutation.

Publications
Publications
Topics
Article Type
Display Headline
Community Oncology Podcast - Targeted therapies in multiple myeloma
Display Headline
Community Oncology Podcast - Targeted therapies in multiple myeloma
Legacy Keywords
Dr. David Henry, Dr. Kenneth C. Anderson, multiple myeloma, Dr. Stuart M. Lichtman, Dr. Jame Abraham, vemurafenib for melanoma, BRAF V600E mutation.
Legacy Keywords
Dr. David Henry, Dr. Kenneth C. Anderson, multiple myeloma, Dr. Stuart M. Lichtman, Dr. Jame Abraham, vemurafenib for melanoma, BRAF V600E mutation.
Article Source

PURLs Copyright

Inside the Article